TrialCell reports. Medicine2026

Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.